跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 17,053 条关于
“Alpha Cognition”
全部
17,053
临床试验
14,533
药物
1,098
机构
33
资讯
1,389
去年
Alpha Cognition Announces Executive Changes and Receives Regulatory Approval
8个月前
Alpha Cognition Launches Real-World Study for ZUNVEYL as Alzheimer's Drug Gains Commercial Traction
去年
Alpha Cognition's ZUNVEYL Receives FDA Approval for Alzheimer's Treatment, Set for Q1 2025 Launch
去年
FDA Approves Zunveyl, a Novel Oral Galantamine Formulation, for Alzheimer's Symptoms
去年
FDA Approves Alpha Cognition's ZUNVEYL® for Mild-to-Moderate Alzheimer's Disease
2年前
FDA Approves Zunveyl (benzgalantamine) for Mild-to-Moderate Alzheimer's Disease
去年
China Medical System Secures NMPA Acceptance for ZUNVYL Alzheimer's Drug Application
去年
Cognition Therapeutics' CT1812 Shows Promise in Phase 2 Trials for Alzheimer's and Lewy Body Dementia
去年
Cambridge Cognition Advances Digital Assessment Tool for Schizophrenia-Related Cognitive Impairment
去年
Alpha Tau Secures MDSAP Certification for Alpha DaRT Cancer Therapy Manufacturing Facility
第 1 页,共 139 页
上一页
下一页